David Beidler

2.5k total citations
30 papers, 2.1k citations indexed

About

David Beidler is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, David Beidler has authored 30 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in David Beidler's work include Cannabis and Cannabinoid Research (7 papers), Cancer therapeutics and mechanisms (6 papers) and Hemoglobinopathies and Related Disorders (4 papers). David Beidler is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Cancer therapeutics and mechanisms (6 papers) and Hemoglobinopathies and Related Disorders (4 papers). David Beidler collaborates with scholars based in United States, Canada and United Kingdom. David Beidler's co-authors include Muneesh Tewari, Vishva M. Dixit, Guy G. Poirier, Paul D. Friesen, Yung Chi Cheng, Sarah E. Smith, Douglas S. Johnson, Cory M. Stiff, Benjamin F. Cravatt and Marya Liimatta and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

David Beidler

30 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Beidler United States 22 1.1k 662 332 310 242 30 2.1k
Waldemar Gonsiorek United States 19 552 0.5× 514 0.8× 933 2.8× 450 1.5× 336 1.4× 28 2.0k
Osamu Nakanishi Japan 27 2.1k 2.0× 143 0.2× 128 0.4× 569 1.8× 394 1.6× 76 3.1k
Sofía Torres Spain 25 1.0k 1.0× 672 1.0× 329 1.0× 533 1.7× 254 1.0× 28 2.4k
Raymond F. Brown United States 9 2.3k 2.2× 159 0.2× 612 1.8× 519 1.7× 284 1.2× 12 3.6k
Le Yu China 25 932 0.9× 166 0.3× 136 0.4× 357 1.2× 152 0.6× 57 1.7k
Makoto Kawatani Japan 31 1.2k 1.1× 322 0.5× 71 0.2× 244 0.8× 410 1.7× 85 2.5k
Dulcie B. Schmidt United States 27 891 0.8× 149 0.2× 592 1.8× 419 1.4× 558 2.3× 55 2.4k
Mir F. Ahmad United States 11 2.1k 1.9× 112 0.2× 418 1.3× 465 1.5× 203 0.8× 13 2.8k
Nicole Fehrenbacher Denmark 16 1.9k 1.8× 113 0.2× 266 0.8× 241 0.8× 137 0.6× 19 3.1k
B Thiele Germany 21 1.3k 1.2× 176 0.3× 230 0.7× 105 0.3× 45 0.2× 57 2.0k

Countries citing papers authored by David Beidler

Since Specialization
Citations

This map shows the geographic impact of David Beidler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Beidler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Beidler more than expected).

Fields of papers citing papers by David Beidler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Beidler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Beidler. The network helps show where David Beidler may publish in the future.

Co-authorship network of co-authors of David Beidler

This figure shows the co-authorship network connecting the top 25 collaborators of David Beidler. A scholar is included among the top collaborators of David Beidler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Beidler. David Beidler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soderstrom, Catherine, Jennifer L. Larsen, David J. Gifondorwa, et al.. (2022). Development and Validation of a Western Blot Method to Quantify Mini-Dystrophin in Human Skeletal Muscle Biopsies. The AAPS Journal. 25(1). 12–12. 3 indexed citations
2.
Barve, Ruteja A., et al.. (2013). Transcriptional profiling and pathway analysis of CSF-1 and IL-34 effects on human monocyte differentiation. Cytokine. 63(1). 10–17. 39 indexed citations
3.
Ahn, Kay, Sarah E. Smith, Marya Liimatta, et al.. (2011). Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain. Journal of Pharmacology and Experimental Therapeutics. 338(1). 114–124. 191 indexed citations
4.
Meyers, Marvin J., Scott A. Long, Matthew J. Pelc, et al.. (2011). Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain. Bioorganic & Medicinal Chemistry Letters. 21(21). 6545–6553. 23 indexed citations
5.
Meyers, Marvin J., Scott A. Long, Matthew J. Pelc, et al.. (2011). Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: Identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds. Bioorganic & Medicinal Chemistry Letters. 21(21). 6538–6544. 17 indexed citations
6.
Eda, Hiroyuki, Hideaki Shimada, David Beidler, & Joseph B. Monahan. (2010). Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts. Rheumatology International. 31(11). 1525–1530. 87 indexed citations
7.
Eda, Hiroyuki, Jian Zhang, Robert H. Keith, et al.. (2010). Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood. Cytokine. 52(3). 215–220. 65 indexed citations
8.
Ahn, Kay, Douglas S. Johnson, Mauro Mileni, et al.. (2009). Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain. Chemistry & Biology. 16(4). 411–420. 373 indexed citations
9.
Wang, Jane L., Barbara A. Schweitzer, Joseph J. McDonald, et al.. (2009). Structure based design of novel irreversible FAAH inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(20). 5970–5974. 9 indexed citations
10.
Johnson, Douglas S., Kay Ahn, Suzanne R. Kesten, et al.. (2009). Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH). Bioorganic & Medicinal Chemistry Letters. 19(10). 2865–2869. 59 indexed citations
11.
Liu, Rebecca, et al.. (1999). Overexpression of Bcl-xL Promotes Chemotherapy Resistance of Mammary Tumors in a Syngeneic Mouse Model. American Journal Of Pathology. 155(6). 1861–1867. 77 indexed citations
12.
Beidler, David, Deepika Ahuja, Max S. Wicha, & Peter L. Toogood. (1999). Inhibition of protein synthesis by didemnin B is not sufficient to induce apoptosis in human mammary carcinoma (MCF7) cells. Biochemical Pharmacology. 58(6). 1067–1074. 24 indexed citations
13.
Murren, John R., Shannon W. Anderson, G Pizzorno, et al.. (1997). Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer.. Journal of Clinical Oncology. 15(1). 148–157. 35 indexed citations
14.
Murren, John R., David Beidler, & Yung Chi Cheng. (1996). Camptothecin Resistance Related to Drug‐induced Down‐Regulation of Topoisomerase I and to Steps Occurring after the Formation of Protein‐linked DNA Breaksa. Annals of the New York Academy of Sciences. 803(1). 74–92. 14 indexed citations
15.
Tewari, Muneesh, David Beidler, & Vishva M. Dixit. (1995). CrmA-inhibitable Cleavage of the 70-kDa Protein Component of the U1 Small Nuclear Ribonucleoprotein during Fas- and Tumor Necrosis Factor-induced Apoptosis. Journal of Biological Chemistry. 270(32). 18738–18741. 149 indexed citations
16.
Beidler, David, Muneesh Tewari, Paul D. Friesen, Guy G. Poirier, & Vishva M. Dixit. (1995). The Baculovirus p35 Protein Inhibits Fas- and Tumor Necrosis Factor-induced Apoptosis. Journal of Biological Chemistry. 270(28). 16526–16528. 309 indexed citations
17.
Beidler, David & Yung Chi Cheng. (1995). Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity.. Molecular Pharmacology. 47(5). 907–914. 88 indexed citations
18.
Basson, Marc D., et al.. (1994). Effect of tyrosine kinase inhibition on basal and epidermal growth factor‐stimulated human Caco‐2 enterocyte sheet migration and proliferation. Journal of Cellular Physiology. 160(3). 491–501. 31 indexed citations
19.
Stern, David F., Pan Zheng, David Beidler, & Cynthia Zerillo. (1991). Spk1, a New Kinase from Saccharomyces cerevisiae , Phosphorylates Proteins on Serine, Threonine, and Tyrosine. Molecular and Cellular Biology. 11(2). 987–1001. 115 indexed citations
20.
Beidler, David, et al.. (1989). Resistance to pyrazofurin and 6-azauridine in normal MC3T3-E1 murine osteoblasts. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1014(2). 101–107. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026